EBP

Across TCGA pan-cancer cohorts, EBP Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated EBP data layer compared with 24 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher EBP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EBP expression acts as an unfavorable survival marker.

KIRC, SKCM, and UCEC are the cancer types where EBP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.172	0.805	.001	24	view →
SKCM	OS	Median	All	0.145	0.783	<.001	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

EBP–KIRC (OS)

Open the KIRC breakdown →